Polycystic Ovary Syndrome (PCOS), newly rebranded as Polyendocrine Ovarian Syndrome (PMOS), represents a prevailing endocrine and metabolic disorder afflicting women in their reproductive years, with incidence rates reaching up to 13% globally. This intricate syndrome manifests through a multifaceted interplay of hormonal dysregulation, insulin resistance, metabolic aberrations, and systemic inflammation. These disruptions collectively contribute to hallmark clinical features such as irregular menstrual cycles, adiposity, and an escalated propensity for cardiovascular morbidity and type 2 diabetes mellitus.
While traditionally recognized during reproductive years, burgeoning evidence elucidates that the sequelae of PMOS extend well into the perimenopausal and menopausal phases of a woman’s life. The physiological hormonal fluctuations inherent to these later stages exacerbate longstanding metabolic and endocrine perturbations triggered by PMOS, complicating the clinical landscape. This convergence heightens the risk profile for cardiometabolic diseases and impairs overall disease management as symptoms intertwine with age-related hormonal changes, underscoring a critical gap in research targeting midlife and older women with PMOS.
Beyond classic metabolic ramifications, many women endure chronic pain syndromes and compromised quality of life, phenomena not fully explained by conventional psychiatric diagnoses such as depression or anxiety. This suggests a more pervasive biopsychosocial impact of PMOS that transcends mere hormonal imbalance, warranting comprehensive therapeutic strategies that encompass mental health and pain management.
Addressing these unmet needs, Florida Atlantic University investigators embarked on a rigorous scoping review synthesizing extant literature examining non-pharmacological and non-surgical interventions for PMOS management across the lifespan, with a focus on perimenopausal and menopausal women. This methodical analysis meticulously filtered over 2,200 publications from 2000 to 2024 down to 29 robust peer-reviewed studies comprising clinical trials, cohort analyses, and systematic reviews centered on lifestyle modifications, complementary therapies, and symptom-specific interventions.
Findings reveal that lifestyle approaches—particularly structured diet and physical exercise regimens—garner the most substantial evidence supporting improvements in both metabolic function and mental health outcomes. Exercise uniquely associates with dual benefits, enhancing insulin sensitivity, body composition, and cardiovascular markers, while concurrently alleviating psychological distress and mood disorders. Dietary modifications consistently yielded beneficial effects on metabolic parameters, including glycemic control and adiposity reduction.
By contrast, the landscape of complementary and alternative therapies presents an equivocal picture. Although investigated across a spectrum of modalities—spanning vitamin D supplementation, omega-3 fatty acids, probiotics, and diverse herbal compounds—the clinical impact on mental health and chronic pain remains poorly elucidated. Notably, only a scant number of studies addressed chronic pain directly, often defaulting to supplement-based interventions rather than structured pain management protocols. This signals a conspicuous research void in fully characterizing and effectively addressing chronic pain syndromes in PMOS.
Dr. Candy Wilson, the study’s primary investigator and a recognized expert in nursing research and scholarship, emphasizes the pronounced imbalance within the evidence base. She notes, “While metabolic outcomes related to diet and exercise have been extensively probed, critical dimensions such as chronic pain and psychological burden are virtually neglected, despite their profound implications for patient quality of life.”
This analysis underscores the imperative for more integrated, person-centered care paradigms. Such approaches should synergistically combine lifestyle interventions with complementary therapies, while holistically targeting the physical, psychological, and nociceptive domains affected by PMOS. Developing multidimensional, lifespan-spanning management strategies is essential to counteract the exacerbation of symptoms observed during perimenopause and menopause.
Dr. Lea Sacca, a senior author and population health specialist at FAU’s medical school, further articulates the urgency for broadened research foci: “The paucity of data addressing key aspects of PMOS beyond its metabolic manifestations, particularly in midlife women, hampers the evolution of comprehensive care models. Advancing understanding of chronic pain and mental health in this context is paramount.”
Epidemiologically, PMOS exerts a profound public health burden. In the United States alone, an estimated 5 to 6 million women are affected, with diagnostic rates as low as 30%, leaving the majority undiagnosed and untreated. The syndrome’s pathophysiology heavily implicates insulin resistance, present in 50–70% of cases, which dramatically amplifies risk for type 2 diabetes by a factor of four. Cardiovascular morbidity statistics parallel this trend, encompassing elevated rates of hypertension, stroke, and other vascular diseases, independent of obesity metrics.
Psychiatric comorbidities compound the complexity; women with PMOS face a tripled risk of depression and up to fivefold increased incidence of anxiety disorders. These mental health challenges, alongside entrenched metabolic dysfunction and chronic pain, collectively erode quality of life and contribute to premature mortality, with studies linking PMOS to a nearly 50% higher risk of early death predominantly from cardiometabolic causes.
This reconceptualization of PMOS as a lifelong disorder necessitates recalibrated clinical approaches. As Dr. Wilson articulates, “Healthcare professionals, notably nurses, occupy a pivotal role in recognizing the intertwined cardiometabolic, psychologic, and pain-related sequelae of PMOS, facilitating holistic, sustained care that aligns with patients’ individual goals and promotes self-management.”
The study’s multidisciplinary authorship, spanning nursing, medicine, and medical librarianship, epitomizes the collaborative ethos required to propel PMOS research forward. Their integrative review published in the American Journal of Lifestyle Medicine charts a foundational course towards more nuanced and effective interventions, bridging reproductive endocrinology with geriatric care paradigms.
Ultimately, addressing the multifaceted burdens of PMOS through evidence-informed lifestyle, complementary, and comprehensive care strategies promises to ameliorate the health trajectories of millions of women globally, extending well beyond reproductive years into the rhythms of aging.
Subject of Research: People
Article Title: Lifestyle and Complementary Approaches to Polycystic Ovary Syndrome During Perimenopause and Menopause: A Scoping Review
News Publication Date: 18-Mar-2026
Web References:
- Florida Atlantic University: https://www.fau.edu/
- American Journal of Lifestyle Medicine (Article DOI link): http://dx.doi.org/10.1177/155982762614367
References:
- Wilson, C., Sacca, L., Chiang-Hanisko, L., et al. (2026). Lifestyle and Complementary Approaches to Polycystic Ovary Syndrome During Perimenopause and Menopause: A Scoping Review. American Journal of Lifestyle Medicine. https://doi.org/10.1177/155982762614367
Image Credits: Alex Dolce, Florida Atlantic University
Keywords: Polycystic Ovary Syndrome, Polyendocrine Ovarian Syndrome, PMOS, Perimenopause, Menopause, Insulin Resistance, Metabolic Dysfunction, Chronic Pain, Mental Health, Lifestyle Intervention, Diet, Exercise, Complementary Therapies
